In cervical cancer cell lines, overexpression of SFRP2 was found to decrease nuclear β-catenin levels, and consequently downregulated gene expression of the cell cycle regulators C-myc and Cyclin D1 [42]. This evidence concerns the gene SFRP2 and cervical carcinoma.